Header Logo

Connection

Masebole Masenya to Raltegravir Potassium

Back to Details
This is a "connection" page, showing publications Masebole Masenya has written about Raltegravir Potassium.
Masebole Masenya
Connection Strength
0,169
Raltegravir Potassium
  1. Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis. AIDS. 2019 11 15; 33(14):2197-2203.
    View in: PubMed
    Score: 0,169
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.